Ezetimibe compositions
US9095515B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2010 |
| Grant date | Aug 4, 2015 |
| Priority date | — |
| Expiry date | Aug 7, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/397
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is a novel pharmaceutical composition of ezetimibe or a pharmaceutically acceptable salt thereof comprising one or more pharmaceutically acceptable excipients having high bioavailability with improved solubility and dissolution rate which is stable throughout the shelflife, methods for their preparation, and methods for treatment using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.